These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7945525)

  • 1. Management of viral infections with thymopentin.
    Sundal E; Bertelletti D
    Arzneimittelforschung; 1994 Jul; 44(7):866-71. PubMed ID: 7945525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymopentin treatment of rheumatoid arthritis.
    Sundal E; Bertelletti D
    Arzneimittelforschung; 1994 Oct; 44(10):1145-9. PubMed ID: 7818590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of thymopentin in the prevention of recurrent infections of the respiratory system. Multicenter study].
    Tovo PA; De Martino M; Rossi P; Cavagni G; Masi M; Bardare M
    Minerva Pediatr; 1993 Dec; 45(12):505-10. PubMed ID: 8145686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variations of the immunological parameters and the clinical response in 25 children treated with thymopentin].
    Melaranci C; Giammaria P
    Pediatr Med Chir; 1991; 13(6):609-12. PubMed ID: 1806920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of dermatoses of viral and non-viral etiology with interferon].
    Borzov MV; Kuznetsov VP; Lobanovskiĭ GI
    Vrach Delo; 1974; 4():149-51. PubMed ID: 4831848
    [No Abstract]   [Full Text] [Related]  

  • 6. Thymopentin prophylactic treatment in patients with recurrent respiratory infections.
    Sundal E
    Br J Clin Pract; 1993; 47(4):198-204. PubMed ID: 8260339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further investigations on thymopentin-like fragments of HLA-DQ and their analogs.
    Szewczuk Z; Wieczorek Z; Stefanowicz P; Wilczyński A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):335-41. PubMed ID: 9523010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
    Haneke E; Bolla K; Degreef H; Djawari D; Demaubeuge J; Molin L; Panconesi E; Schöpf E; Stengel R; Stingl G
    Int J Clin Pharmacol Res; 1984; 4(6):439-43. PubMed ID: 6085327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRI-514, a synthetic peptide analogue of thymopentin, reduces the behavioral response to social stress in rats.
    Menzaghi F; Heinrichs SC; Vargas-Cortes M; Goldstein G; Koob GF
    Physiol Behav; 1996 Aug; 60(2):397-401. PubMed ID: 8840897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antiviral drugs that target herpesvirus helicase primase enzymes.
    Kleymann G
    Herpes; 2003 Aug; 10(2):46-52. PubMed ID: 14577954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
    Morfin F; Frobert E; Thouvenot D
    Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of viral oral mucosal diseases].
    Haneke E
    Quintessenz; 1983 Jul; 34(7):1407-13. PubMed ID: 6583738
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges and options in the management of viral infections after stem cell transplantation.
    Reusser P
    Support Care Cancer; 2002 Apr; 10(3):197-203. PubMed ID: 11904784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Office management of viral skin infections in the elderly.
    Raimer SS; Pursley TV
    Geriatrics; 1981 Feb; 36(2):53-63. PubMed ID: 7450510
    [No Abstract]   [Full Text] [Related]  

  • 15. [The immunomodulating action of thymopentin in acute and chronic stress].
    Vazhnichaia EM; Tarasenko LM; Deviatkina TA; Klusha VE
    Farmakol Toksikol; 1991; 54(1):38-40. PubMed ID: 1860496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of thymopentin. Data from European clinical studies.
    Weiss P; Stocker H
    Surv Immunol Res; 1985; 4 Suppl 1():149-54. PubMed ID: 3898288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivirals against DNA viruses (hepatitis B and the herpes viruses).
    Hewlett G; Hallenberger S; Rübsamen-Waigmann H
    Curr Opin Pharmacol; 2004 Oct; 4(5):453-64. PubMed ID: 15351349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mother-infant and indirect transmission of HSV infection: treatment and prevention].
    Henrot A
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):533-49. PubMed ID: 12122323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of activity, synthesis and biological testing of anti-HSV active peptides.
    Jenssen H; Gutteberg TJ; Rekdal Ø; Lejon T
    Chem Biol Drug Des; 2006 Jul; 68(1):58-66. PubMed ID: 16923027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
    Tyler KL
    Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.